Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 151.0 | 48 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 138.0 | 51 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 146.0 | 45 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 171.5 | 38 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | LIF | 176.0 | 51 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 218.0 | 35 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | LIF | 216.0 | 28 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 222.0 | 35 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | LIF | 221.5 | 34 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 44.0 | 38 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 51.0 | 43 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 53.0 | 42 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 57.5 | 38 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 44.5 | 38 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 61.0 | 37 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 45.0 | 41 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | LIF | 55.0 | 44 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 94.0 | 35 | |
N2645 | TNF-a | 100 | ng/mL | 4 | LIF | 99.5 | 38 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 65.0 | 31 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | LIF | 65.0 | 34 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | LIF | 40.0 | 27 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | LIF | 38.0 | 29 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | LIF | 46.0 | 37 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | LIF | 45.0 | 39 |